Metraipolis › archive › dc_e4c1c09caec2
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42194809
- DOI
- 10.3390/jcm15103850
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T16:16:13.901Z
- SHA-256 of the archived text
31e6203cfbcf7979779e263e6fa34075e5fd8077b5ffe87493033b7f0a9b77a0- Stable URL of this page
https://metraipolis.com/documento/dc_e4c1c09caec2
How to cite
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809 — Europe PMC (en), https://europepmc.org/article/MED/42194809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4c1c09caec2 (Metraipolis archive dc_e4c1c09caec2, sha256 31e6203cfbcf7979779e263e6fa34075e5fd8077b5ffe87493033b7f0a9b77a0)
BibTeX
@misc{dce4c1c09caec2,
title = {Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors — Europe PMC PMID:42194809},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42194809},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4c1c09caec2; sha256 31e6203cfbcf7979779e263e6fa34075e5fd8077b5ffe87493033b7f0a9b77a0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194809. Agents can read the archived copy with the MCP tool read_document.